Search tips
Search criteria 


Logo of nihpaAbout Author manuscriptsSubmit a manuscriptHHS Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;
Microbes Infect. Author manuscript; available in PMC 2013 August 1.
Published in final edited form as:
PMCID: PMC3389182

Transcriptome analysis of HeLa cells response to Brucella melitensis infection: A molecular approach to understand the role of the mucosal epithelium in the onset of the Brucella pathogenesis


Brucella spp. infect hosts primarily by adhering and penetrating mucosal surfaces, however the initial molecular phenomena of this host:pathogen interaction remain poorly understood. We hypothesized that characterizing the epithelial-like human HeLa cell line molecular response to wild type Brucella melitensis infection would help to understand the role of the mucosal epithelium at the onset of the Brucella pathogenesis. RNA samples from B. melitensis-infected HeLa cells were taken at 4 and 12 h of infection and hybridized in a cDNA microarray. The analysis using a dynamic Bayesian network modeling approach (DBN) identified several pathways, biological processes, cellular components and molecular functions altered due to infection at 4 h p.i., but almost none at 12 h p.i. The in silico modeling results were experimentally tested by knocking down the expression of MAPK1 by siRNA technology. MAPK1-siRNA transfected cell cultures decreased the internalization and impaired the intracellular replication of the pathogen in HeLa cells after 4 h p.i. DBN analysis provides important insights into the role of the epithelial cells response to Brucella infection and guide research to novel mechanisms identification.

Keywords: Brucella melitensis, HeLa cells, Microarray, Bayesian, Modeling, MAPK1 gene

1. Introduction

Brucella is the etiological agent of brucellosis, a worldwide anthropozoonotic infectious disease. Human brucellosis is an occupational-related disease. The highest risk group includes shepherds, animal handlers, farmers and farm workers, butchers, abattoir workers, meat processing plant workers, veterinarians and their assistants, and personnel in microbiologic laboratories. Transmission is associated with accidental contact with infected animals or clinical specimens, inhalation of infected aerosolized particles or foodborne disease associated with the consumption of contaminated animal products [1]. Clinically, human brucellosis is an incapacitating disease that results in intermittent fever, chills, sweats, weakness, myalgia, osteoarthricular complications, endocarditis, depression and anorexia, but low mortality [2]. The severity of the symptoms and signs in humans vary depending on the species of Brucella: B. melitensis causes the most severe and acute symptoms, followed by B. suis, while B. abortus and B. canis tend to produce milder disease and subclinical infections [2]. Among animal species, most mammals are susceptible to brucellosis. Placentitis, abortion and temporary infertility are the principal clinical manifestations of brucellosis in pregnant females. Brucella infection in males causes orchitis and inflammation of the accessory sex organs resulting in permanent or temporary infertility [3].

One of the most attractive topics on Brucella research is to more fully understand the prolonged ability of the pathogen to survive and replicate inside macrophages for long time. It is also important to highlight that Brucella infect susceptible hosts by penetrating mucosal surfaces [4]. Therefore, epithelial cells constitute the first mechanical and immunological barrier against Brucella infection on which few studies have been focused. HeLa cells have been used as a model to understand adhesion, internalization, intracellular trafficking, survival, and replication of brucellae in non-professional phagocytic cells [58]. These and other studies have shown that individual Brucella initially attach to non-professional phagocytic cells via receptor molecules containing sialic acid or sulfated residues [5] and within a few minutes are internalized by receptor–mediated phagocytosis [9]. After invasion, Brucella transiently interact with intracellular compartment related to the early endocytic network that is gradually transformed into a multimembranous autophagic vacuole. The expression of virB operon through type IV secretion system (T4SS) allows virulent brucellae to control the maturation of the Brucella-containing vacuole (BCV) to generate a replicative organelle derived from the endoplasmic reticulum in the perinuclear area, where massive intracellular replication occurs [8, 10]. Despite the importance of epithelial cells in the initial Brucella pathogenesis, a detailed molecular response of these cells infected with the intracellular pathogen has not been fully investigated.

Several tools have been developed to study the transcriptional profiles of both pathogen and host [11], the most common of which is cDNA microarray technology. Recently using this approach, we demonstrated that B. melitensis undergo an adaptation period during the first 4 h post HeLa cells infection that is subsequently overcome, facilitating Brucella to replicate intracellularly [12]. With the goal of identifying molecular perturbations in host cells due to B. melitensis infection, we measured the host cells response at 4 and 12 h of infection by a human cDNA microarray, and analyzed the results using a dynamic Bayesian network modeling approach (DBN).

2. Materials and methods

2.1. Cell culture infection and RNA isolation

Eight biological replicas of HeLa cell cultures were infected with a late-log growth phase culture of a virulent B. melitensis 16M, as previously described [12]. Eight other HeLa cell cultures were equally treated with diluent as non-infected controls. Total RNA was extracted from 4 infected and 4 non-infected HeLa cell cultures at 4 and 12 h post-infection (p.i.) using TRI-Reagent® (Ambion, Austin, TX) according to manufacturer’s instructions. Isolated RNA were treated and maintained as previously reported [12].

2.2. Sample preparation and slide hybridization

The labeling and hybridization procedures were adapted from our previous experiments [13]. Briefly, 10 μg of total RNA were reverse transcribed overnight to amino-allyl cDNA using 6 μg of random hexamer primers (Invitrogen), 0.6 μl 50X dNTPs (Invitrogen) / aa-dUTP (Ambion) mix (2:3 aa-dUTP:dTTP) and 400U Superscript III (Invitrogen). cDNA was labeled with Cy5-ester (experimental samples, i.e. infected and non infected samples) or Cy3-ester (human universal human reference RNA, Stratagene, La Jolla, CA) (Amersham Pharmacia Biosciences). After one hour incubation in the dark, uncoupled dye was removed and dye incorporation calculated by NanoDrop® ND-1000 (NanoDrop). The dried, labeled cDNA samples were re-suspended in 20 μl of nuclease-free water (experimental samples) and human genomic DNA Cot1 (Invitrogen) (reference samples), mixed and heated at 95°C for 10 min, 60°C for 10 min, and then 25°C for 10 min. Samples were kept at 45°C until hybridization. Immediately before hybridization, 40 μl of 2X formamide-based hybridization buffer was added to each sample, well mixed and hybridized to a commercially available 10K human ESTs microarray (Microarray Center, Ontario, Canada). Slides were hybridized at 45°C for ~20 h in a dark, humid chamber (Corning) and washed for 10 min at 45°C with low stringency buffer [1X SSC, 0.2% SDS] followed by two 5-min washes in a higher stringency buffer [0.1X SSC, 0.2% SDS and 0.1X SSC] at room temperature with agitation. Slides were dried by centrifugation at 800X g for 2 min and immediately scanned. Prior to hybridization, microarrays were pre-treated by washing in 0.2% SDS, followed by 3 washes in distilled water and incubated in prehybridization buffer [5X SSC, 0.1% SDS; 1% BSA in 100ml of water] at 45°C for at least 45 min. Immediately before hybridization, the slides were washed 4 times in distilled water, dipped in 100% isopropanol for 10 sec and dried by centrifugation at 1,000X g for 2 min.

2.3. Data acquisition and microarray data analysis

Microarrays were scanned using a commercial laser scanner (GenePix 4100; Axon Instruments Inc., Foster City, CA). The genes represented on the arrays were adjusted for background and normalized to internal controls using image analysis software (GenePixPro 6.0; Axon Instruments Inc.). Genes with fluorescent signal values below background were disregarded in all analyses. Arrays were initially normalized against universal human reference RNA [14] and the resulting data were analyzed and modeled using an integrated platform termed the BioSignature Discovery System (BioSignatureDS) (Seralogix, LLC, Austin, TX; explained in detail elsewhere [1517]. Specifically for the analysis reported herein, the tools were used to: 1) conduct biological system level analysis employing Bayesian network models for scoring and ranking of metabolic and signaling pathways and gene ontology (GO) groups; and 2) conduct Bayesian candidate mechanistic gene analysis to identify genes within the network models that are most responsible for causing pathway and GO group perturbations. Microarray data are deposited in GEO database at NCBI (Accession # GSE14703).

Link for reviewers:

2.4. Induction of RNAi in HeLa cells

The day before transfection, HeLa cells were cultured in 24 well plates at a concentration of 4 × 104 cells/well in 0.5 ml of cell culture medium and replaced in the incubator. The following day, 50 μl of serum-free cell growth medium (Invitrogen, Carlsbad, CA) was mixed in separate compartments with 30 nM of Silencer® mitogen-activated protein kinase 1 (MAPK1) (ID 1449) Validated siRNA (Ambion, Austin, TX) for each 24 wells of cells to be transfected. Simultaneously, 1 μl of TransFecting lipid reagent (Bio-Rad, Hercules, CA) was diluted into 50 μl of serum-free cell growth medium for each 24-well culture to be transfected. The diluted siRNA was combined and gently mixed with the diluted transfecting reagent. After 20 min incubation at RT, the culture media was removed from the wells and replaced by 100 μl of the siRNA-TransFecting complexes, rocked for 1 min and then filled with 400 μl of F12K cell culture media supplemented with 10% HI-FBS. The next day, the media in the wells was replaced for 0.5 ml of fresh cell culture medium. Forty-eight hours after transfection, HeLa cells were infected with B. melitensis 16M and invasion and survival of intracellular bacteria was determined as described above. Infection of non-transfected cells and HeLa cells transfected with 30 nM Silencer® negative control #1 siRNA (siRNA molecules with no homology on eukaryotic genome) (Ambion) were used as the scrambled control. For validation of RNAi efficiency, RNA from transfected cells was extracted at the same time of infection (i.e. 48 h post-transfection) using RNeasy kit (Qiagen, Valencia, CA) and eluted in 50 μl of DEPC-treated water with 2% DTT and 1% RNase inhibitor (Promega, Madison, WI). RNAs extracted from HeLa cells transfected with 30 nM of Silencer® GAPDH siRNA control and negative control #1 siRNA (Ambion) were used for validation of knocked down gene expression. Contaminant genomic DNA was removed by RNase-free DNase I treatment (Ambion) according to the manufacture’s instructions, and samples were stored at -80°C until used. The concentration of RNA was quantitated by NanoDrop® ND-1000 (NanoDrop, Wilmington, DW), and the quality RNA was assessed using the Agilent 2100 Bioanalyzer (Agilent, Palo Alto, CA). Target mRNA levels were measured by qRT-PCR using the following primers (Sigma Genosys, The Woodlands, TX): MAPK1 (Fw 5′-TGGATTCCCTGGTTCTCTCTAAAG-3′, Rv 5′-GGGTCTGTTTTCCGAGGATGA-3′) and GAPDH (Glyceraldehide-3-phosphate dehydrogenase: Fw 5′-AAAAACCTGCCAAATATGATGACA-3′, Rv 5′-AGCTTGACAAAGTGGTCGTTGA-3′).

3. Results

3.1. Dynamic Bayesian modeling analysis of microarray data reveals a scant disturbance of host pathways and GO categories at 4 h that return to a near normal state by 12 h post-B. melitensis infection

To understand the host cells response at the molecular level throughout Brucella infection process, we analyzed the infected host cells transcriptome at the adaptation and the replicative phases of the intracellular pathogen (i.e. 4 and 12 h p.i.) [12]. Four biological replicates of RNA isolated from B. melitensis-infected HeLa cells from every time point (4 and 12 h p.i.) were indirectly labeled and co-hybridized with human universal RNA reference to a commercial 10K human array (n = 8). Gene expression was indirectly compared with RNA isolated from non-infected HeLa cells treated similarly (n = 8). The RNA analyzed from all samples was of good to excellent quality (RNA integrity number (RIN) ≥ 7.0, 28S/18S ratio ≥ 1.6, OD260/280 ≥ 1.75, OD260/230 ≥ 1.7).

Mathematical modeling has great potential for discovering and understanding disease mechanisms and biological processes. To better understand the molecular response of host cells after Brucella infection, BioSignatureDS was used to model and score 219 known host metabolic and signaling pathways and more than a 2,000 ontology terms (biological processes, molecular functions and cellular components). The Dynamic Bayesian Gene Group Activation (DBGGA) method which generates Bayesian log likelihood scores that are normalized and transformed to a z-score equivalent (hereafter Bayesian z-score) was employed to identify the perturbations between pathways and GO categories and indicate candidate mechanistic genes.

The analysis identified only 8 pathways significantly altered (Bayesian z-score >|2.24|) at 4 h p.i., but at 12 h p.i., none of the 219 signaling/metabolic pathways associated with gene probes on the human microarrays were perturbed when infected and non-infected host cells were compared (Table 1). Deeper Bayesian analysis identified 37 unique mechanistic genes in the 8 pathways determined to be significantly altered (Table 1). Note that MAPK1 was a mechanistic gene in common with three of the perturbed pathways and was selected for further examination (see paragraph 3.2 below). These data illustrate the potential for cross-talk via inter-pathway interactions and pathways activation in the process of infection and that small alterations in expression of any of these 37 genes can have significant effects on other genes and simultaneously on other pathways, as suggested in the dynamic Bayesian modeling results. As an example, Fig. 1 shows the visualization of the MAPK signaling pathway network model with candidate mechanistic genes highlighted with orange concentric rings. This model was trained with the experiment and control expression data for the two sampling time points. The visualization helps to identify the relationships between genes as well as the expression state of the gene for the selected time point. The MAPK1 gene is identified to have the potential influence on a number of important downstream genes (Fig. 1) such as MYC (v-myc myelocytomatosis viral oncogene homolog) and ELK4 (ETS-domain protein (SRF accessory protein 1).

Figure 1
B. melitensis-infected HeLa cells MAPK signaling pathway with mechanistic genes
Table 1
Pathways significantly altered at 4 h p.i. in B. melitensis-infected cells compared with non-infected HeLa cells and key mechanistic genes within each pathway

A DBGGA analysis conducted over 2,000 gene ontology (GO) terms, identified 203 GO terms that belonged within the biological processes term (94 up- and 109 down-regulated), 38 belonged to the cellular components term (13 up- and 25 down-regulated) and 28 to molecular functions term (19 up- and 9 down-regulated), highly perturbed (|Bayesian z-score| >2.24) at 4 h p.i. (Tables 2, ,33 and and4).4). However, only 2 biological processes GO categories (vesicle coating –GO:0006901- and regulation of lipid metabolic process –GO:0019216-) but neither cellular component nor molecular function terms were significantly altered (activated) at 12 h p.i. In the ontology of biological processes, the most significant changes occurred in terms related with regulation of biological processes, cell proliferation and developmental processes, metabolic processes, response to stimulus, and immune system processes. The number of terms related with that processes is almost equally activated or repressed in all of them at 4 h post-Brucella infection, except in cell proliferation and developmental processes and immune system processes, where most terms are repressed (Table 2). Examples include central nervous system development (GO:0007417), heart morphogenesis (GO:0003007), embryonic development (GO:0009790) and hemopoiesis (GO:0030097) terms for cell proliferation and developmental processes, while T and B cell differentiation and proliferation (GO:0030217, GO:0030183, GO:0042098, GO:0046651), inflammatory response to antigenic stimulus (GO:0002437), and positive regulation of immune response (GO:0050778) terms are good examples of the repression of the immune system processes. In the GO cellular components, the most significant changes were focused on terms related with nuclear parts (Cajal body –GO:0015030-, chromosome telomeric and centromeric region –GO:0000781 and GO:0000775-, chromosomal part –GO:0044427-), membrane parts (membrane raft –GO:0045121-, plasma membrane part –GO:0044459-, cell projection membrane –GO:0031253-) and cytoskeleton parts (microtubule cytoskeleton –GO:0015630-, actin filament –GO:00005884-) (Table 3), while in the molecular function GO, the most significant changes are equally distributed among binding (RNA binding –GO:0003723-, enzyme binding –GO:0019899-), enzyme regulator activity (small GTPase regulator activity –GO:0005083-, protein kinase regulator activity –GO:0019887-) and catalytic activity (kinase activity –GO:0016301-, pyrophosphatase activity –GO:0016462-) (Table 4).

Table 2
Gene Ontology (GO) biological processes differentially expressed (determined by Bayesian z-score) in infected compare to non-infected HeLa cells at 4 h p.i. identified by dynamic Bayesian modeling
Table 3
Gene Ontology (GO) cellular components differentially expressed (determined by Bayesian z-score) in infected compare to non-infected HeLa cells at 4 h p.i. identified by dynamic Bayesian modeling
Table 4
Gene Ontology (GO) molecular function differentially expressed (determined by Bayesian z-score) in infected compare to non-infected HeLa cells at 4 h p.i. identified by dynamic Bayesian modeling

Overall, these results indicate that host metabolic and signaling pathways and GO groups are more pronouncedly perturbed by Brucella infection at very early time post-infection and return to a near normal state by 12 h p.i.

3.2. Role of MAPK1 in Brucella pathogenicity

To evaluate our in silico modeling results, we experimentally tested the role of MAPK1, one of the predicted mechanistic genes during Brucella infection to HeLa cells (Table 1 and Fig. 1). HeLa cells were transfected with MAPK1-validated siRNA molecule and 48 h later were infected with B. melitensis WT. The expression of MAPK1 measured by qRT-PCR in transfected cell cultures were knocked down more than 90% compared with the expression of the gene in non-transfected cells or cells transfected with negative and positive control siRNA molecules (data not shown). The number of viable intracellular Brucella recovered from HeLa cell culture transfected with MAPK1 at T0 was only 40% of the number of bacteria recovered from non-transfected HeLa cells (P < 0.01) (Fig. 2). Additionally, the intracellular replication of Brucella after 4 h p.i. was repressed in HeLa cell cultures transfected with siRNA-MAPK1 compared to controls. These experimental results were in accord with our predictive in silico algorithm and defined the importance of MAPK1 in Brucella replication and survival in non-professional phagocytic cells.

Figure 2
Effect of MAPK-siRNA molecule on the invasion of HeLa cells by Brucella melitensis

4. Discussion

Using cDNA microarray technology, we have characterized the transcriptional profile of Brucella –infected non phagocytic cells at 4 and 12 h p.i. Recently, we analyzed the transcriptional profile of the intracellular Brucella following Hela cells infection at same time points, which correspond to the adaptation and the replicative phases of the pathogen at the intracellular level [12]. A general overview from the combined analysis of the results from the host and pathogen transcriptional profiles indicates that, while Brucella initially repress and then stimulate its gene expression, the infection initially altered several key pathways and biological processes GO categories in host cells that return to a near normal state by 12 h p.i. All together, our results provide evidence that both non-phagocytic cells and Brucella undergo an adaptation period during the first 4 h p.i. that is overcome by 12 h p.i. permitting Brucella to replicate intracellularly while minimally affecting host physiological processes.

To the best of our knowledge, this is the first study analyzing the transcriptomic profile of non-phagocytic cell response to Brucella infection. Previous studies have described the molecular response of professional phagocytic cells at different time points after Brucella infection [13, 1821]. Eskra et al. and Covert et al. found quite similar number of genes up- and down-regulated in a murine macrophage cell line infected with different Brucella species at 4 h p.i. [18, 19]. In general, genes associated with immune and inflammatory response were up-regulated, and genes involved in cell cycle/cell division/proliferation and differentiation, intracellular trafficking and metabolism were down-regulated. In another study, He et al. evaluated the transcriptional profile of B. melitensis-infected murine macrophages at different time points. In agreement with our data, they found that the most significant transcriptional changes occurred early after infection (4 h) and returned to normal at later time points (between 24 and 48 h) [20]. Coincidently, in a recent publication Wang et al. also found an active transcriptional activity (> 3,000 host genes) by deep-sequencing analysis of the mouse macrophage response to 2 different B. melitensis strains at 4 h post infection [21]. Altogether, these results suggest that the intracellular presence of Brucella induces an intense early host cell molecular response that normalizes at later time points.

In order to evaluate not only individual genes/proteins, but also to identify which pathways or biological processes were most perturbed in one condition relative to another, we applied the Dynamic Bayesian Gene Group Activation. Three pathways among the 8 significantly altered in B. melitensis-infected HeLa cells (Table 1) such as bladder cancer, Huntington’s disease and MAPK signaling pathway, have been previously found differentially expressed in mouse macrophage response to B. melitensis infection [21]. Mitogen-Activated Protein Kinase (MAPK) signaling pathway has been demonstrated to be implicated in bacterial pathogenesis. Internalization and intracellular survival and replication of different bacterial pathogens are dependent on MAPK pathways activation [2225]. To test the in silico model and identify the importance of this MAPK signaling pathway in B. melitensis invasion and intracellular survival in HeLa cells, we used siRNA technology to knock-down MAPK1 expression and interrupt the pathway activation. Our results indicated that the internalization of Brucella decreased when the gene was knocked-down and the intracellular replication of the pathogen was impaired after 4 h p.i., highlighting the importance of the pathway integrity to Brucella invasion and survival process in these cells. These results are in agreement with Guzman-Verri et al., who reported that pretreatment of HeLa cells with PD098059, an ERK1/2 pathway inhibitor, resulted in a 50% decrease in Brucella internalization [6]. MAPKs family of proteins regulates cellular activities by phosphorylating target protein substrates such as cytoskeletal proteins. Those authors have demonstrated the participation of GTPases of the Rho/Rac/Cdc42 subfamily in B. abortus internalization in non-phagocytic cells [6]. MAPK1 is in a downstream pathway activated by these small GTPase subfamily proteins [26], thus it is plausible that any interruption of this signaling pathway may adversely impact the process of Brucella invasion in epithelial cells. Interestingly, activation of MAP kinases MEK-1 and ERK-2 genes (also known as MAPK1) is also part of the signaling required for uptake of Listeria monocytogenes by epithelial cells, but not for Salmonella invasion [25]. These findings could probably be related with the very different invasion mechanisms evolved from each pathogen: while Listeria induce a “zipper” mechanism, Salmonella is internalized by a “trigger” mechanism [27]. According to these and previous results [6], Brucella would exploit similar cell signal transduction pathways similar to Listeria for invasion of epithelial cells. Contrary, virulent smooth Brucella do not activate MAPK pathways when invade mouse macrophages [21, 28], probably as a self-defensive mechanism, because MAPK pathway activation contributes to eliminate intracellular Brucella by inducing immune responses [28, 29]. Based on this and previous results, we hypothesize that some Brucella virulent factors other than LPS [28] are activated upon contact to epithelial cells, but not to macrophages, to induce MAPK signaling pathway activation and invasion stimulation. Collectively, these results provide other examples of how pathogens manipulate host metabolic and signaling pathways for it own benefit. Additional studies focused on MAPK pathway regulation during Brucella infection will further clarify the role(s) of this signaling pathway in Brucella pathogenesis.

Particularly important in infectious disease is the host immune response to pathogen invasion. The influence of the epithelium in the initiation of the immune response in Brucella infection has been inadequately studied. Salmonella typhimurium is known to stimulate the Toll-like receptor signaling pathway in intestinal epithelial cells, resulting in IL8 secretion and a massive neutrophil influx into the intestinal lumen [22]. Also Legionella pneumophila, another intracellular pathogen, is reported to induce secretion of several cytokines from the lung epithelium after infection, which contributes to the immune response in legionellosis [30]. Brucella has developed a stealth strategy that allows it to reach its replication niche before activation of antimicrobial mechanisms through the immune response [31]. In a recent publication, Ferrero et al. showed that Brucella-infected human bronchial epithelial cell lines collaborate in mounting a host innate immune response [32]. An overview of our DBGGA analysis indicates that GO biological processes terms related with the immune system process had reduced expression. Deeper analysis found that “complement and coagulation cascades” pathway as well as biological processes GO terms related to complement activation, coagulation cascade and antigen processing and presentation were significantly activated, while those related to lymphocyte differentiation and proliferation were repressed (Table 2, terms marked with *). MHC-I is present in all nucleated cells of the body, while MHC-II expression is restricted to immune cells. Lapaque et al. have shown that Brucella LPS has no effect on MHC class I antigen presentation in infected macrophages [33]. This is in agreement with our in silico modeling results and may indicate a pathogen manipulation of host defensive mechanisms, as it was observed that cells with reduced levels of MHC-I molecules are target of NK cells. Also in support of our analysis, Brucella infection consumes complement, although less than when compared to Salmonella [31]. Moreover, Brucella LPS is directly involved in deficient CD4+ T cells activation [34] which is consistent with our data that indicating repressed lymphocyte differentiation, proliferation and activation.

In conclusion, we have documented the molecular response of the epithelium-like HeLa cell line during the first 12h post-Brucella infection. Our results indicate that Brucella infection perturbs epithelial cell biology at very early time post-infection and then returns to near normal state by 12 h p.i. without significantly interfering with the fate of the pathogen. In vivo, Brucella invade and traverse the epithelium layer of susceptible hosts and are endocytosed by mucosal macrophages. Based on our results and published literature, we propose that quickly after invasion, Brucella drive the infected cells through an active transcriptional activity toward an adaptive period that appears to be necessary and crucial for successful persistence of intracellular pathogen. During this adaptive period Brucella not only regulate their own survival but also modulate host epithelial cells response for their benefit. For example, here we showed that MAPK1 expression is necessary for Brucella invasion and intracellular replication in non-phagocytic cells. Simultaneously, at very early times post-infection Brucella modulate host adaptive immune response through epithelial cells, down-regulating the lymphocytes differentiation, proliferation and activation (i.e. adaptive immunity). All these mechanisms contribute to the ability of Brucella to quickly adapt to an intracellular life and reach their replication niche, where they initiate replication without significant disruption of host processes. Further analysis of the computational integrated results of host and pathogen molecular response, along with experimental confirmation are expected to further unravel the initial molecular pathogenesis of Brucella.


We thank Dr. Tomas A. Ficht for providing the B. melitensis 16M strain and Dr. Renée M. Tsolis and Sara D. Lawhon for critical reading of the manuscript. This study was supported by U.S. Department of Homeland Security – National Center of Excellence for Foreign Animal and Zoonotic Disease (FAZD) Defense grant ONR-N00014-04-1-0 and a NIH grant 2U54AI057156-06. The computational analysis completed by Seralogix was supported in part by the National Institutes of Allergies and Infectious Diseases SBIR grants 2R44AI058362-02 and R43AI084223-01. C.A.R. was sponsored by Fulbright-INTA scholarship from Argentina. This work was part of the C.A.R. doctoral dissertation.


Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.


1. Pappas G, Akritidis N, Bosilkovski M, Tsianos E. Brucellosis. N Engl J Med. 2005;352:2325–2336. [PubMed]
2. Young EJ. An overview of human brucellosis. Clin Infect Dis. 1995;21:283–290. [PubMed]
3. Enright FM. The pathogenesis and pathobiology of Brucella infection in domestic animals. In: Nielsen K, Duncan JR, editors. Animal brucellosis. CRC Press; Boca Raton, Florida: 1990. pp. 301–320.
4. Olsen SC, Thoen CO, Cheville NF. Brucella. In: Gyles CL, Prescott JF, Songer JG, Thoen CO, editors. Pathogenesis of bacterial infections in animals. Blackwell Publishing Ltd; Ames, Iowa: 2004. pp. 309–319.
5. Castaneda-Roldán EI, Avelino-Flores F, Dall’Agnol M, Freer E, Cedillo L, Dornand J, Girón JA. Adherence of Brucella to human epithelial cells and macrophages is mediated by sialic acid residues. Cell Microbiol. 2004;6:435–445. [PubMed]
6. Guzmán-Verri C, Chaves-Olarte E, von Eichel-Streiber C, López-Goni I, Thelestam M, Arvidson S, Gorvel JP, Moreno E. GTPases of the Rho subfamily are required for Brucella abortus internalization in nonprofessional phagocytes. J Biol Chem. 2001;276:44435–44443. [PubMed]
7. Pizarro-Cerdá J, Méresse S, Parton RG, van der Goot G, Sola-Landa A, López-Goni I, Moreno E, Gorvel JP. Brucella abortus transits through the autophagic pathway and replicates in the endoplasmic reticulum of non-professional phagocytes. Infect Immun. 1998;66:5711–5724. [PMC free article] [PubMed]
8. Pizarro-Cerdá J, Moreno E, Sanguedolce V, Mege JL, Gorvel JP. Virulent Brucella abortus prevents lysosome fusion and is distributed within autophagosome-like compartments. Infect Immun. 1998;66:2387–2392. [PMC free article] [PubMed]
9. Detilleux PG, Deyoe BL, Cheville NF. Effect of endocytic and metabolic inhibitors on the internalization and intracellular growth of Brucella abortus in Vero cells. Am J Vet Res. 1991;52:1658–1664. [PubMed]
10. Sieira R, Comerci DJ, Sánchez DO, Ugalde RA. A homologue of an operon required for DNA transfer in Agrobacterium is required in Brucella abortus for virulence and intracellular multiplication. J Bacteriol. 2000;182:4849–4855. [PMC free article] [PubMed]
11. Green CD, Simons JF, Taillon BE, Lewin DA. Open systems: Panoramic views of gene expression. J Immunol Meth. 2001;250:67–79. [PubMed]
12. Rossetti CA, Galindo CL, Garner H, Adams LG. Transcriptional profile of the intracellular pathogen Brucella melitensis following HeLa cells invasion. Microb Pathog. 2011;51:338–344. [PMC free article] [PubMed]
13. Rossetti CA, Galindo CL, Everts RE, Lewin HA, Garner H, Adams LG. Comparative analysis of the early transcriptome of B. abortus infected monocyte-derived macrophages from cattle naturally resistant of susceptible to brucellosis. Res Vet Sci. 2011;91:40–51. [PMC free article] [PubMed]
14. Weil MR, Macatee T, Garner HR. Toward a universal standard: Comparing two methods for standardizing spotted microarray data. BioTechniques. 2002;32:1310–1314. [PubMed]
15. Adams LG, Khare S, Lawhon S, Rossetti CA, Lewin HA, Lipton MS, Turse JE, Wylie DC, Bai Y, Drake K. Enhancing the role of veterinary vaccines reducing zoonotic diseases of humans: linking systems biology with vaccine development. Vaccine. 2011;29:7197–7206. [PMC free article] [PubMed]
16. Adams LG, Khare S, Lawhon S, Rossetti CA, Lewin HA, Lipton MS, Turse JE, Wylie DC, Bai Y, Drake K. Multi-comparative systems biology analysis reveals time-course signatures of in vivo bovine pathway responses to B. melitensis, S. enterica Typhimurium and M. avium paratuberculosis. BMC Proc. 2011;5:S6. [PMC free article] [PubMed]
17. Lawhon S, Khare S, Rossetti CA, Everts RE, Galindo CL, Luciano S, Figueiredo J, Nunes J, Gull T, Davidson GS, Drake K, Garner HR, Lewin HA, Baumler AJ, Adams LG. Role of SPI-1 secreted effectors in acute bovine response to Salmonella enterica serovar Typhimurium: a systems biology analysis approach. PLoS One. 2011;6:e26869. [PMC free article] [PubMed]
18. Covert J, Mathison A, Eskra L, Banai M, Splitter G. Brucella melitensis, B. neotomae and B. ovis elicit common and distinctive macrophage defense transcriptional responses. Exp Biol Med. 2009;234:1450–1467. [PMC free article] [PubMed]
19. Eskra L, Mathison A, Splitter G. Microarray analysis of mRNA levels from RAW264.7 macrophages infected with Brucella abortus. Infect Immun. 2003;71:1125–1133. [PMC free article] [PubMed]
20. He Y, Reichow S, Ramamoorthy S, Ding X, Lathigra R, Craig JC, Sobral BWS, Schurig GG, Sriranganathan N, Boyle SM. Brucella melitensis triggers time-dependent modulation of apoptosis and down-regulation of mitochondrion-associated gene expression in mouse macrophages. Infect Immun. 2006;74:5035–5046. [PMC free article] [PubMed]
21. Wang F, Hu S, Liu W, Qiao Z, Gao Y, Bu Z. Deep-sequencing analysis of the mouse transcriptome response to infection with Brucella melitensis strains of differing virulence. PLoS ONE. 2011;6:e28485. [PMC free article] [PubMed]
22. Hobbie S, Chen LM, Davis RJ, Galán JE. Involvement of mitogen-activated protein kinase pathways in the nuclear responses and cytokine production induced by Salmonella typhimurium in cultured intestinal epithelial cells. J Immunol. 1997;159:5550–5559. [PubMed]
23. Palmer LE, Hobbie S, Galán JE, Bliska JB. YopJ of Yersinia pseudotuberculosis is required for the inhibition of macrophage TNF-alpha production and downregulation of the MAP kinases p38 and JNK. Mol Microbiol. 1998;27:953–965. [PubMed]
24. Schorey JS, Cooper AM. Macrophage signaling upon mycobacterial infection: The MAP kinases lead the way. Cell Microbiol. 2003;5:133–142. [PubMed]
25. Tang P, Sutherland CL, Gold MR, Finlay BB. Listeria monocytogenes invasion of epithelial cells requires the MEK-1/ERK-2 mitogen-activated protein kinase pathway. Infect Immun. 1998;66:1106–1112. [PMC free article] [PubMed]
26. Scita G, Tenca P, Frittoli E, Tocchetti A, Innocenti M, Giardina G, DiFiore PP. Signaling from Ras to Rac and beyond: Not just a matter of GEFs. EMBO J. 2000;19:2393–2398. [PubMed]
27. Cossart P, Sansonetti PJ. Bacterial invasion: The paradigms of enteroinvasive pathogens. Science. 2004;304:242–248. [PubMed]
28. Jiménez de Bagués MP, Gross A, Terraza A, Dornand J. Regulation of the mitogen-activated protein kinases by Brucella spp. expressing a smooth and rough phenotype: Relationship to pathogen invasiveness. Infect Immun. 2005;73:3178–3183. [PMC free article] [PubMed]
29. Jarvis BW, Harris TH, Qureshi N, Splitter GA. Rough lipopolysaccharide from Brucella abortus and Escherichia coli differentially activates the same mitogen-activated protein kinase signaling pathways for tumor necrosis factor alpha in RAW 264.7 macrophage-like cells. Infect Immun. 2002;70:7165–7168. [PMC free article] [PubMed]
30. Schmeck B, N’Guessan PD, Ollomang M, Lorenz J, Zahlten J, Opitz B, Flieger A, Suttorp N, Hippenstiel S. Legionella pneumophila-induced NF-kB and MAPK-dependent cytokine release by lung epithelial cells. Eur Respir J. 2007;29:25–33. [PubMed]
31. Barquero-Calvo E, Chaves-Olarte E, Weiss DS, Guzmán-Verri C, Chacon-Diaz C, Rucavado A, Moriyón I, Moreno E. Brucella abortus uses a stealthy strategy to avoid activation of the innate immune system during the onset of infection. PLoS One. 2007;2:e631. [PMC free article] [PubMed]
32. Ferrero MC, Fossati CA, Baldi PC. Direct and monocyte-induced innate immune response of human lung epithelial cells to Brucella abortus infection. Microbes Infect. 2010;12:736–747. [PubMed]
33. Lapaque N, Moriyón I, Moreno E, Gorvel JP. Brucella lipopolysaccharide acts as a virulence factor. Curr Op Microbiol. 2005;8:60–66. [PubMed]
34. Forestier C, Deleuil F, Lapaque N, Moreno E, Gorvel JP. Brucella abortus lipopolysaccharide in murine peritoneal macrophages acts as a down-regulator of T cell activation. J Immunol. 2000;165:5202–5210. [PubMed]